<code id='EB4638F4F0'></code><style id='EB4638F4F0'></style>
      • <acronym id='EB4638F4F0'></acronym>
      <center id='EB4638F4F0'><center id='EB4638F4F0'><tfoot id='EB4638F4F0'></tfoot></center><abbr id='EB4638F4F0'><dir id='EB4638F4F0'><tfoot id='EB4638F4F0'></tfoot><noframes id='EB4638F4F0'>
      • <optgroup id='EB4638F4F0'><strike id='EB4638F4F0'><sup id='EB4638F4F0'></sup></strike><code id='EB4638F4F0'></code></optgroup>
        5. <b id='EB4638F4F0'><label id='EB4638F4F0'><select id='EB4638F4F0'><dt id='EB4638F4F0'><span id='EB4638F4F0'></span></dt></select></label></b><u id='EB4638F4F0'></u>
          <i id='EB4638F4F0'><strike id='EB4638F4F0'><tt id='EB4638F4F0'><pre id='EB4638F4F0'></pre></tt></strike></i>
          
    
          
      
          
       
      
          
        
      
          
      
          
        
          
          
          
            
          
            
          
              
          
                
          Wikipedia 
          
                
          
                
          
              
          
            
          
            
            
          
          
          
       
        
          
      
          
      
          
        
          
        
          
          
            
          
                           
          Wikipedia  
          
                                   
                 
                                      author：entertainment   
                                        
                                      
                                      Page View：5153
                                  
                                    
          
                                    
          Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit.																									STAT
          Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.
          The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.
          advertisement
          But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Asbestos ban is immediate, but health effects will linger for decades
                                
                            
          Next article：  
                                      
                                          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
                                                                    
          
            
          
           
            
          
          
          
       
          
        
          
        
      
          
      
          
                                                
        
          focus
          
                  
          

                    
          
            
          
              
                Trump demands the U.S. pay no more for drugs than other countries … again
                
          
                        
              
          
                Trump demands the U.S. pay no more for drugs than other countries … again
                
          
                  
          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                Diabetes management: Digital health tools fall short, study says
                
          
                        
              
          
                Diabetes management: Digital health tools fall short, study says
                
          
                  
          AdobeThelastdecadehasseenbillionsofdollarsflowintodigitalhealthcompaniesthatpromisetoimproveoutcomes
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                Drug repurposing or repositioning? The language matters
                
          
                        
              
          
                Drug repurposing or repositioning? The language matters
                
          
                  
          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
         
        
          
          
        
          

          
          
            
          
          
          
            
          'Brian's Song' at 50 still offers lessons about cancer for today
          
            
          BrianPiccolo(41)oftheChicagoBearsbeingstoppedbyKarlKassulke(29)oftheMinnesotaVikingstwoseasonsbefore
          
          
          
          
          
            read more